The CEO of Iconovo, Dr. Orest Lastow, was invited to Shenyang Pharmaceutical University to give one-day seminar on inhalation and inhalation product development. The seminar comprised four lectures and was well attended by graduate, under-graduate students and members of the faculty. Several people from the industry had travelled far from all parts of China to Shenyang to attend the seminar. This seminar was part of Iconovo’s strategy to build industrial and academic co-operations in China.

Shenyang Pharmaceutical University is one of the highest ranked pharmaceutical universities in China and has several groups specializing in inhalation.


Iconovo is hiring a mechanical engineer to further strengthen the full development cycle of medicinal inhalers. You already have experience from product development and innovation. At Iconovo, you will develop inhaled medicines in a project team with pharmaceutical scientists and mechanical engineers. The position is full time and will be based at Iconovo offices at Medicon Village in Lund, Sweden. Read more.

Iconovo is attending RDD (Respiratory Drug Delivery) April 22-26, 2018. Come and visit us at table 63 and we will tell you about our unique devices and our formulation capability.

The shareholders of Iconovo AB, 556938-0156, are invited to the Annual General Meeting on Wednesday 16 May 2018 at 17.30 (CEST) at the premises of Zenit Design AB, Södra Promenaden 9, SE-211 29 Malmö.

Nasdaq welcomes Iconovo to First North.

Erbjudandet i Iconovo övertecknat inför börsnotering på First North. Pressrelease_Iconovo 2018-03-26

Nyhetsbyrån Direkt intervjuar Dr. Orest Lastow, se intervjun här.

Short film about Iconovo #hemmahos. English subtitles available.

Inbjudan till teckning av aktier i Iconovo AB (publ) inför listning på Nasdaq First North. Läs mer om erbjudandet på Stockpicker.